PEMBROLIZUMAB
Clinical trials for PEMBROLIZUMAB explained in plain language.
Never miss a new study
Get alerted when new PEMBROLIZUMAB trials appear
Sign up with your email to follow new studies for PEMBROLIZUMAB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a drug make colon cancer surgery unnecessary?
Disease control Not yet recruitingThis study is testing whether giving an immunotherapy drug (pembrolizumab) before surgery can shrink tumors enough to allow some patients with a specific type of early-stage colon cancer to avoid major surgery. The goal is to see if patients whose cancer disappears after the drug…
Matched conditions: PEMBROLIZUMAB
Phase: PHASE2 • Sponsor: Ismail Gögenur • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC
-
New drug duo aims to halt rare, aggressive cancers
Disease control Not yet recruitingThis study aims to see if a combination of two drugs, zanzalintinib and pembrolizumab, can help control the growth of certain advanced or spreading soft-tissue sarcomas. It will enroll about 20 adults with specific sarcoma subtypes who have not had certain prior treatments. The m…
Matched conditions: PEMBROLIZUMAB
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 16, 2026 15:25 UTC